Loading…

Loading grant details…

Completed HORIZON European Commission

Breast self-reconstruction: The Promise of Breast Reconstruction with patients’ own tissue

€3.48M EUR

Funder European Commission
Recipient Organization Lattice Medical
Country France
Start Date Oct 01, 2022
End Date Sep 30, 2024
Duration 730 days
Number of Grantees 1
Roles Coordinator
Data Source European Commission
Grant ID 190174063
Grant Description

LATTICE MEDICAL develops MATTISSE, a fully degradable 3D printed breast implant allowing a natural and custom breast reconstruction in a single and simple surgery.

MATTISSE technology uses a Tissue Engineering Chamber implanted in the former breast and made of 3D printed biocompatible and bioabsorbable polymer.

MATTISSE regenerates autologous adipose tissue within 3-6 months, women recover a full breast in 18 months with a fully degraded implant at an affordable price and free from numerous surgical procedures. There is no longer any risk related to silicone implants thanks to the complete recovery with natural tissue.

After validating the effectiveness of the MATTISSE medical device on animal models, this project aims at performing the mandatory clinical studies to launch the product on the EU market with the CE mark. A commercial team will be recruited to define and implement a marketing plan to ensure the success of MATTISSE.

Lattice Medical plans to support 40000 women by 2030.

All Grantees

Lattice Medical

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant